Showing results (1-10 of 261) with videos related to

Sort By:
Pageof 27
Journal of Proteome Research|October 28, 2010
Translational proteomics: what can you do for true patients?Cristobal Belda-Iniesta, Javier de Castro, Rosario Perona
BMJ Case Reports|July 18, 2012
Foot pain: uncommon presentation of lung cancerAngela Lamarca, Nadia Hindi, Cristobal Belda-Iniesta, et al.
International Journal of Clinical and Experimental Pathology|June 6, 2015
Biomarkers of erlotinib response in non-small cell lung cancer tumors that do not harbor the more common epidermal growth factor receptor mutationsBlanca D López-Ayllón, Javier de Castro-Carpeño, Carlos Rodriguez, et al.
Current Stem Cell Research & Therapy|June 9, 2009
Suppressing glioblastoma stem cell function by aldehyde dehydrogenase inhibition with chloramphenicol or disulfiram as a new treatment adjunct: an hypothesisRichard E Kast, Cristobal Belda-Iniesta
Cancer Causes & Control : CCC|July 29, 2004
Implications of oxidative stress and cell membrane lipid peroxidation in human cancer (Spain)Paloma Cejas, Enrique Casado, Cristobal Belda-Iniesta, et al.
Pharmaceutics|June 24, 2022
Choline Kinase α Inhibitors MN58b and RSM932A Enhances the Antitumor Response to Cisplatin in Lung Tumor CellsJuan Carlos Lacal, Rosario Perona, Javier de Castro, et al.
Cancer Medicine|June 26, 2014
Cancer stem cells and cisplatin-resistant cells isolated from non-small-lung cancer cell lines constitute related cell populationsBlanca D Lopez-Ayllon, Veronica Moncho-Amor, Ander Abarrategi, et al.
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
Drug resistance in cancer immunotherapy: new strategies to improve checkpoint inhibitor therapiesJesus Rodriguez-Pascual, Angel Ayuso-Sacido, Cristobal Belda-Iniesta
Cancer Letters|June 26, 2009
MKP1 repression is required for the chemosensitizing effects of NF-kappaB and PI3K inhibitors to cisplatin in non-small cell lung cancerMaría Cortes-Sempere, Sharmila Chattopadhyay, Ana Rovira, et al.
Epigenetics|December 9, 2014
Methylation status of IGFBP-3 as a useful clinical tool for deciding on a concomitant radiotherapyOlga Pernía, Cristobal Belda-Iniesta, Veronica Pulido, et al.
Pageof 27